Vitacrystallography: Appearance and Development of Cancer-Induced Structural Biomarkers in a Mouse Model
- Oleksii Avdieiev 1, Sergey A Denisov 1,2, Ashkan Ajeer 3, Lois Adams 3, Charlene Greenwood 3, Heather Nesbitt 4, Keith Thomas 5, Keith Rogers 1,6, Olga Solovyeva 1, Lev Mourokh 1,7, Pavel Lazarev 1
- Oleksii Avdieiev 1, Sergey A Denisov 1,2, Ashkan Ajeer 3
- 1EosDx UK Ltd., 5 New Street Square, London EC4A 3TW, UK.
- 2Institut de Chimie Physique, UMR8000, CNRS, Université Paris-Saclay, Bât. 349, 91405 Orsay, France.
- 3School of Chemical and Physical Sciences, Keele University, Keele ST5 5BG, UK.
- 4School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine BT52 1SA, Co. Londonderry, Northern Ireland, UK.
- 5School of Biomedical Sciences, Ulster University, Coleraine BT52 1SA, Co. Londonderry, Northern Ireland, UK.
- 6Shrivenham Campus, Cranfield University, Swindon SN6 8LA, UK.
- 7Physics Department, Queens College, City University of New York, 65-30 Kissena Blvd, Flushing, NY 11367, USA.
- 0EosDx UK Ltd., 5 New Street Square, London EC4A 3TW, UK.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers discovered a new structural biomarker for prostate cancer using X-ray scattering. This biomarker, based on lipid and water ratios, tracks cancer progression and can aid in early disease detection and monitoring treatment effectiveness.
Area Of Science
- Biophysics
- Medical Imaging
- Oncology
Background
- Conventional diagnostics for diseases like prostate cancer can be complemented by structural biomarkers.
- X-ray scattering offers a method for identifying these biomarkers within tissues.
Purpose Of The Study
- To investigate the potential of X-ray scattering for detecting and monitoring prostate cancer progression.
- To identify a novel structural biomarker for prostate cancer in mouse models.
Main Methods
- Prostate cancer was induced in mouse models, with one lobe inoculated and the other left as a control.
- Tissue samples were collected at various time points and analyzed using X-ray scattering.
- Structural changes were assessed by examining the ratio of X-ray scattering peaks related to lipids and water.
Main Results
- A distinct ratio between X-ray scattering peaks for lipids and water was identified as a structural biomarker for prostate cancer.
- This biomarker demonstrated a developmental trajectory that correlated with tumor advancement.
- The biomarker's progression along its trajectory indicated disease progression or healing.
Conclusions
- The lipid-to-water X-ray scattering ratio serves as a viable structural biomarker for prostate cancer.
- This biomarker can be used to establish a baseline for disease staging and monitor treatment efficacy.
- X-ray scattering analysis provides a pathway for early disease detection and personalized patient management.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

